Anaptysbio (ANAB) Accumulated Depreciation & Amortization (2016 - 2025)
Anaptysbio (ANAB) has disclosed Accumulated Depreciation & Amortization for 10 consecutive years, with $7.1 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 1078.05% year-over-year to $7.1 million, compared with a TTM value of $7.1 million through Dec 2025, up 1078.05%, and an annual FY2025 reading of $7.1 million, up 1078.05% over the prior year.
- Accumulated Depreciation & Amortization was $7.1 million for Q4 2025 at Anaptysbio, up from $428000.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $7.1 million in Q4 2025 and bottomed at $125000.0 in Q1 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $715900.0, with a median of $378500.0 recorded in 2023.
- The sharpest move saw Accumulated Depreciation & Amortization decreased 10.71% in 2021, then soared 1078.05% in 2025.
- Year by year, Accumulated Depreciation & Amortization stood at $619000.0 in 2021, then increased by 9.05% to $675000.0 in 2022, then dropped by 3.41% to $652000.0 in 2023, then decreased by 7.06% to $606000.0 in 2024, then skyrocketed by 1078.05% to $7.1 million in 2025.
- Business Quant data shows Accumulated Depreciation & Amortization for ANAB at $7.1 million in Q4 2025, $428000.0 in Q3 2025, and $288000.0 in Q2 2025.